| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -380 K | 100% | $3.35 | -$1.27 M |
| Net | -5 | -380 K | -100% | -$1.27 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 10%+ Owner | $61.1 M | Jun 17, 2024 | ||
| Denise Scots-Knight | Chief Executive Officer, Director | $3.27 M | -$463 K | -12.4% | Jun 25, 2024 |
| Charles Sermon | General Counsel | $873 K | -$162 K | -15.6% | Jun 25, 2024 |
| Christine Fox | Chief Financial Officer | $443 K | -$148 K | -25% | Jun 25, 2024 |
| John A. Lewicki | Chief Scientific Officer | $352 K | -$84.4 K | -19.3% | Jun 25, 2024 |
| Michael S. Wyzga | Director | $145 K | Jun 17, 2024 | ||
| Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | $117 K | -$413 K | -77.9% | Jun 25, 2024 |
| Jeremy Bender | Director | $95.5 K | Jun 17, 2024 | ||
| Anders Ekblom | Director | $83.8 K | Feb 8, 2024 | ||
| Daniel Shames | Director | $45.5 K | Feb 8, 2024 | ||
| Pierre Jacquet | Director | $45.5 K | Feb 8, 2024 | ||
| Deepika Pakianathan | Director | $45.5 K | Feb 8, 2024 | ||
| Annalisa Jenkins | Director | $45.5 K | Feb 8, 2024 | ||
| Marc J. Yoskowitz | Director | $45.5 K | Feb 8, 2024 | ||
| Justin Hunter Roberts | Director | Jan 1, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|